Information about Neola Medical IPO 2020
In 2020, Neola Medical initiated a process to be listed on the Nasdaq First North Growth Market in Stockholm. Here we collect information linked to that process.
As part of listing Neola Medical, Gasporox, which founded the company, has chosen to distribute its entire holding in Neola Medical to Gasporox’s shareholders. For more information about the dividend, visit www.gasporox.se or read more in the information brochure below/to the right.
SEK 6.40 per unit, which corresponds to SEK 6.40 per share.
A unit consists of one (1) share and one (1) warrant.
The warrants are issued free of charge.
Brokerage is not canceled.
A maximum of 3,515,625 units, which means a maximum of 3,515,625 shares and a maximum of 3,515,625 warrants of series TO1.
Neola Medical will receive SEK 22.5 million before deductions for issue costs upon full subscription in the Offer. The issue costs for the Offer amount to
about 2.1 MSEK.
Warrants of series TO1
One (1) warrant entitles the holder to subscribe for one (1) share at a subscription price of SEK 8.32 during the period October 4, 2021 through October 29, 2021. Upon fully subscribed Offer and full exercise of the TO1 series warrants, Neola Medical will receive an additional 29 SEK 3 million before deductions for issue costs of approximately SEK 1.2 million.
The greenshoe option consists of a maximum of 527,343 newly issued units. The units issued in the greenshoe option shall have the same subscription price as those in the Offer.
Approximately SEK 45 million before the Offer.
Subscription commitments approximately SEK 18 million, corresponding to 80 percent of the Offer.
September 7, 2020 – September 21, 2020.
Publication of results around 22 September 2020.
September 30, 2020.
Preliminary first trading day October 2, 2020 on Nasdaq First North.
Minimum subscription item
820 units corresponding to SEK 5,248. Each unit consists of one (1) share and one (1) warrant.